Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 2013. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a specific transaction on April 11, 2013, where Mrs. K Thomson (Connected Person to Director Mr. P C Thomson) acquired 13 Ordinary Shares. The acquisition occurred at a price of 1560.192 pence per share through the reinvestment of dividends under the GlaxoSmithKline ShareReward Plan.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the share transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Facts for Investor Verification
- Transaction Date: April 11, 2013.
- Connected Person: Mrs. K Thomson (related to Director Mr. P C Thomson).
- Shares Acquired: 13 Ordinary Shares.
- Price per Share: 1560.192 pence.
- Source of Acquisition: Reinvestment of dividends via the GlaxoSmithKline ShareReward Plan.
- Notification Date: April 12, 2013.